Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

NET PROFIT (x1000 DKK)

EMPLOYEES

Share

Annexin Pharmaceuticals AB (publ)

Closing information (x1000 DKK)

Closing information 2023/12 2022/12 2021/12
Turnover 0 Equal arrow 0 Equal arrow 0
Financial expenses 0 More Arrow 1 More Arrow 1,352
Earnings before taxes -29,590 More Arrow -27,214 Less Arrow -37,914
EBITDA -29,672 More Arrow -27,213 Less Arrow -37,253
Total assets 17,976 More Arrow 24,510 More Arrow 38,382
Current assets 16,735 More Arrow 22,486 More Arrow 36,878
Current liabilities 5,339 Less Arrow 4,361 More Arrow 4,406
Equity capital 12,637 More Arrow 20,149 More Arrow 33,977
- share capital 3,853 Less Arrow 1,709 More Arrow 19,958
Employees (average) 4 More Arrow 5 Equal arrow 5

Financial ratios

Fiscal year 2023/12 2022/12 2021/12
Solvency 70.3% More Arrow 82.2% More Arrow 88.5%
Turnover per employee 0 Equal arrow 0 Equal arrow 0
Profit as a percentage of turnover
Return on assets (ROA) -164.6% More Arrow -111.0% More Arrow -95.3%
Current ratio 313.4% More Arrow 515.6% More Arrow 837.0%
Return on equity (ROE) -234.2% More Arrow -135.1% More Arrow -111.6%
Change turnover 0 Equal arrow 0 Equal arrow 0
Change turnover %
Chg. No. of employees -1 More Arrow 0 More Arrow 1
Chg. No. of employees % -20% More Arrow 0% More Arrow 25%

Total value of public sale

Fiscal year 2023/12 2022/12 2021/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.